455

Compound name
Erdafitinib
Alt Name
JNJ-42756493
Balversa
Compound Image
Erdafitinib.png
SMILES
CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC
MW
446.50
Brutto
C25H30N6O2
InChI
InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3
InChI Key
OLAHOMJCDNXHFI-UHFFFAOYSA-N
Approval Jurisdiction
2019 FDA
Approved for clinical use
Advanced Metastatic Urothelial Carcinoma
CAS
1346242-81-6
PubChem CID
67462786
Action
FGFRs
Approved Drug List
1
Commercial Vendor
Janssen